Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Testing effectiveness (Phase 2)Study completedNCT00075881
What this trial is testing

Bortezomib in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
National Cancer Institute (NCI) 44
Not applicableNot Yet RecruitingNCT06726330
What this trial is testing

Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer

Who this might be right for
Tubo-ovarian CarcinomaHigh-grade Serous CarcinomaPrimary Peritoneal Carcinoma Stage III+2 more
Centre Oscar Lambret 1,100
Not applicableStudy completedNCT05114772
What this trial is testing

Pre Procedural Biomarkers Might Predict Recurrent Atrial Fibrillation After Catheter Ablation

Who this might be right for
Atrial Fibrillation
Tanta University 117
Testing effectiveness (Phase 2)Looking for participantsNCT04776395
What this trial is testing

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
Emory University 68
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Testing effectiveness (Phase 2)Study completedNCT02395666
What this trial is testing

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Who this might be right for
Neuroblastoma
Giselle Sholler 140
Large-scale testing (Phase 3)Study completedNCT03009981
What this trial is testing

Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance Foundation Trials, LLC. 504
Post-approval studies (Phase 4)UnknownNCT05580354
What this trial is testing

Safety and Efficacy of BCG Combined With Tislelizumab for BCG-untreated Patients With High-risk Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Ruijin Hospital 42
Not applicableEnded earlyNCT04556929
What this trial is testing

Enhanced Detection in Glioma Excision

Who this might be right for
Glioma
University of Oxford 4
Not applicableActive Not RecruitingNCT07014553
What this trial is testing

Effect of Web-based Nursing Navigator Programme on Breast Cancer Screening Behaviors in Women at High Risk of Breast Cancer

Who this might be right for
Breast Cancer Risk
Istanbul University - Cerrahpasa 104
Early research (Phase 1)Ended earlyNCT04458259
What this trial is testing

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

Who this might be right for
Neoplasm Metastasis
Pfizer 88
Testing effectiveness (Phase 2)Looking for participantsNCT06762782
What this trial is testing

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

Who this might be right for
Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
The First Affiliated Hospital with Nanjing Medical University 276
Very early researchActive Not RecruitingNCT05477823
What this trial is testing

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 30
Large-scale testing (Phase 3)Study completedNCT02393859
What this trial is testing

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Leukemia, Acute Lymphoblastic
Amgen 111
Testing effectiveness (Phase 2)UnknownNCT04935580
What this trial is testing

Study of FasT CAR-T GC012F Injection in High Risk TE NDMM Patients

Who this might be right for
Multiple Myeloma
Shanghai Changzheng Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04838496
What this trial is testing

Induction Chemotherapy for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Catharina Ziekenhuis Eindhoven 128
Not applicableStudy completedNCT00617370
What this trial is testing

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Memorial Sloan Kettering Cancer Center 38
Testing effectiveness (Phase 2)UnknownNCT01047969
What this trial is testing

Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy

Who this might be right for
Rectal Adenocarcinoma
Royal Marsden NHS Foundation Trust 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT03876769
What this trial is testing

Study of Efficacy and Safety of Tisagenlecleucel in HR B-ALL EOC MRD Positive Patients

Who this might be right for
B-Cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 121
Next Page